EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Using Extraction and Evaluation of Explanations for Drug-Repurposing on Knowledge Graphs

Kara Schatz, Jon-Michael Beasley, Cleber Melo-Filho, Alexander Tropsha, Rada Chirkova

ACM Transactions on Computing for Healthcare · 2027-01-31 · 8 (1) · 1-36

DOI: 10.1145/3820155 ↗

At a glance

Journal article in ACM Transactions on Computing for Healthcare, published online on 2026-11-16. Written by Kara Schatz and 4 co-authors. 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institutes of Health, National Science Foundation, Research Triangle Institute.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Knowledge Graph (KG) databases represent information about real-world entities (via nodes) and relationships between them (via edges) in the form of semantic networks. We consider the problem of reliably inferring novel relationships between KG entities, with applications in drug repurposing, the area of biomedical research that focuses on identifying new uses for existing drugs. Inferring novel drug–disease relationships can be viewed in drug repurposing as generation of testable hypotheses, which can then be validated in preclinical or clinical studies. Thus, reliable KG generation of noteworthy drug-treats-disease hypotheses would be of value in those cases in which biomedical information is available through large-scale KGs. We introduce a scalable domain- and task-agnostic approach for extracting from KGs explainable hypotheses and for providing data-supported evaluations of the explanations for their potential noteworthiness. Our explanations take the form of KG patterns that are evaluated using our proposed metrics; in the drug-repurposing domain, they can be interpreted as drug-treats-disease hypotheses that can be further analyzed by biomedical experts. Through broad-ranging experiments, we provide evidence for our extracted explanations being understandable and reasonable to domain experts, and for the proposed metrics being accurate. These findings suggest that the approach can be a viable tool in drug repurposing to extract and evaluate explanations for potential drug-treats-disease hypotheses.

Funding

  • National Institutes of Health
  • National Science Foundation
  • Research Triangle Institute

Cite

APA

Schatz, K., Beasley, J., Melo-Filho, C., Tropsha, A., & Chirkova, R. (2027). Using Extraction and Evaluation of Explanations for Drug-Repurposing on Knowledge Graphs. ACM Transactions on Computing for Healthcare, 8(1), 1-36. https://doi.org/10.1145/3820155

Vancouver

Schatz K, Beasley J, Melo-Filho C, Tropsha A, Chirkova R. Using Extraction and Evaluation of Explanations for Drug-Repurposing on Knowledge Graphs. ACM Transactions on Computing for Healthcare. 2027;8(1):1-36. doi:10.1145/3820155

BibTeX
@article{Schatz2027,
  author = {Schatz, Kara and Beasley, Jon-Michael and Melo-Filho, Cleber and Tropsha, Alexander and Chirkova, Rada},
  title = {Using Extraction and Evaluation of Explanations for Drug-Repurposing on Knowledge Graphs},
  journal = {ACM Transactions on Computing for Healthcare},
  year = {2027},
  volume = {8},
  number = {1},
  pages = {1--36},
  doi = {10.1145/3820155}
}
Start for free →